Pharma & Healthcare

Global CGRP Targeting Drugs for Migraine Market Research Report 2026

This report delivers a comprehensive overview of the global CGRP Targeting Drugs for Migraine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CGRP Targeting Drugs for Migraine. The CGRP Targeting Drugs for Migraine market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global CGRP Targeting Drugs for Migraine market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist CGRP Targeting Drugs for Migraine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AbbVie Inc.
Pfizer Inc.
Lundbeck
Alder Therapeutics
Teva
Lilly Inc.
Amgen Inc.
Novartis International AG
Daiichi Sankyo Co., Ltd.
Segment by Type
CGRP Receptor Antagonists
CGRP Monoclonal Antibodies
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for CGRP Targeting Drugs for Migraine companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CGRP Targeting Drugs for Migraine Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 CGRP Receptor Antagonists
1.2.3 CGRP Monoclonal Antibodies
1.3 Market by Application
1.3.1 Global CGRP Targeting Drugs for Migraine Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CGRP Targeting Drugs for Migraine Market Perspective (2021–2032)
2.2 Global CGRP Targeting Drugs for Migraine Growth Trends by Region
2.2.1 Global CGRP Targeting Drugs for Migraine Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 CGRP Targeting Drugs for Migraine Historic Market Size by Region (2021–2026)
2.2.3 CGRP Targeting Drugs for Migraine Forecasted Market Size by Region (2027–2032)
2.3 CGRP Targeting Drugs for Migraine Market Dynamics
2.3.1 CGRP Targeting Drugs for Migraine Industry Trends
2.3.2 CGRP Targeting Drugs for Migraine Market Drivers
2.3.3 CGRP Targeting Drugs for Migraine Market Challenges
2.3.4 CGRP Targeting Drugs for Migraine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CGRP Targeting Drugs for Migraine Players by Revenue
3.1.1 Global Top CGRP Targeting Drugs for Migraine Players by Revenue (2021–2026)
3.1.2 Global CGRP Targeting Drugs for Migraine Revenue Market Share by Players (2021–2026)
3.2 Global Top CGRP Targeting Drugs for Migraine Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by CGRP Targeting Drugs for Migraine Revenue
3.4 Global CGRP Targeting Drugs for Migraine Market Concentration Ratio
3.4.1 Global CGRP Targeting Drugs for Migraine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CGRP Targeting Drugs for Migraine Revenue in 2025
3.5 Global Key Players of CGRP Targeting Drugs for Migraine Head Offices and Areas Served
3.6 Global Key Players of CGRP Targeting Drugs for Migraine, Products and Applications
3.7 Global Key Players of CGRP Targeting Drugs for Migraine, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 CGRP Targeting Drugs for Migraine Breakdown Data by Type
4.1 Global CGRP Targeting Drugs for Migraine Historic Market Size by Type (2021–2026)
4.2 Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Type (2027–2032)
5 CGRP Targeting Drugs for Migraine Breakdown Data by Application
5.1 Global CGRP Targeting Drugs for Migraine Historic Market Size by Application (2021–2026)
5.2 Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America CGRP Targeting Drugs for Migraine Market Size (2021–2032)
6.2 North America CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America CGRP Targeting Drugs for Migraine Market Size by Country (2021–2026)
6.4 North America CGRP Targeting Drugs for Migraine Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CGRP Targeting Drugs for Migraine Market Size (2021–2032)
7.2 Europe CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe CGRP Targeting Drugs for Migraine Market Size by Country (2021–2026)
7.4 Europe CGRP Targeting Drugs for Migraine Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CGRP Targeting Drugs for Migraine Market Size (2021–2032)
8.2 Asia-Pacific CGRP Targeting Drugs for Migraine Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (2021–2026)
8.4 Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CGRP Targeting Drugs for Migraine Market Size (2021–2032)
9.2 Latin America CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America CGRP Targeting Drugs for Migraine Market Size by Country (2021–2026)
9.4 Latin America CGRP Targeting Drugs for Migraine Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size (2021–2032)
10.2 Middle East & Africa CGRP Targeting Drugs for Migraine Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (2021–2026)
10.4 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. CGRP Targeting Drugs for Migraine Introduction
11.1.4 AbbVie Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.1.5 AbbVie Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. CGRP Targeting Drugs for Migraine Introduction
11.2.4 Pfizer Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.2.5 Pfizer Inc. Recent Development
11.3 Lundbeck
11.3.1 Lundbeck Company Details
11.3.2 Lundbeck Business Overview
11.3.3 Lundbeck CGRP Targeting Drugs for Migraine Introduction
11.3.4 Lundbeck Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.3.5 Lundbeck Recent Development
11.4 Alder Therapeutics
11.4.1 Alder Therapeutics Company Details
11.4.2 Alder Therapeutics Business Overview
11.4.3 Alder Therapeutics CGRP Targeting Drugs for Migraine Introduction
11.4.4 Alder Therapeutics Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.4.5 Alder Therapeutics Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva CGRP Targeting Drugs for Migraine Introduction
11.5.4 Teva Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.5.5 Teva Recent Development
11.6 Lilly Inc.
11.6.1 Lilly Inc. Company Details
11.6.2 Lilly Inc. Business Overview
11.6.3 Lilly Inc. CGRP Targeting Drugs for Migraine Introduction
11.6.4 Lilly Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.6.5 Lilly Inc. Recent Development
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Details
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. CGRP Targeting Drugs for Migraine Introduction
11.7.4 Amgen Inc. Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.7.5 Amgen Inc. Recent Development
11.8 Novartis International AG
11.8.1 Novartis International AG Company Details
11.8.2 Novartis International AG Business Overview
11.8.3 Novartis International AG CGRP Targeting Drugs for Migraine Introduction
11.8.4 Novartis International AG Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.8.5 Novartis International AG Recent Development
11.9 Daiichi Sankyo Co., Ltd.
11.9.1 Daiichi Sankyo Co., Ltd. Company Details
11.9.2 Daiichi Sankyo Co., Ltd. Business Overview
11.9.3 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Introduction
11.9.4 Daiichi Sankyo Co., Ltd. Revenue in CGRP Targeting Drugs for Migraine Business (2021–2026)
11.9.5 Daiichi Sankyo Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CGRP Targeting Drugs for Migraine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of CGRP Receptor Antagonists
Table 3. Key Players of CGRP Monoclonal Antibodies
Table 4. Global CGRP Targeting Drugs for Migraine Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global CGRP Targeting Drugs for Migraine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global CGRP Targeting Drugs for Migraine Market Size by Region (US$ Million), 2021–2026
Table 7. Global CGRP Targeting Drugs for Migraine Market Share by Region (2021–2026)
Table 8. Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global CGRP Targeting Drugs for Migraine Market Share by Region (2027–2032)
Table 10. CGRP Targeting Drugs for Migraine Market Trends
Table 11. CGRP Targeting Drugs for Migraine Market Drivers
Table 12. CGRP Targeting Drugs for Migraine Market Challenges
Table 13. CGRP Targeting Drugs for Migraine Market Restraints
Table 14. Global CGRP Targeting Drugs for Migraine Revenue by Players (US$ Million), 2021–2026
Table 15. Global CGRP Targeting Drugs for Migraine Market Share by Players (2021–2026)
Table 16. Global Top CGRP Targeting Drugs for Migraine Players by Tier (Tier 1, Tier 2, and Tier 3), based on CGRP Targeting Drugs for Migraine Revenue, 2025
Table 17. Ranking of Global Top CGRP Targeting Drugs for Migraine Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by CGRP Targeting Drugs for Migraine Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of CGRP Targeting Drugs for Migraine, Headquarters and Area Served
Table 20. Global Key Players of CGRP Targeting Drugs for Migraine, Products and Applications
Table 21. Global Key Players of CGRP Targeting Drugs for Migraine, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global CGRP Targeting Drugs for Migraine Market Size by Type (US$ Million), 2021–2026
Table 24. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Type (2021–2026)
Table 25. Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Type (2027–2032)
Table 27. Global CGRP Targeting Drugs for Migraine Market Size by Application (US$ Million), 2021–2026
Table 28. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Application (2021–2026)
Table 29. Global CGRP Targeting Drugs for Migraine Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Application (2027–2032)
Table 31. North America CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2021–2026
Table 33. North America CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2027–2032
Table 34. Europe CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2021–2026
Table 36. Europe CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Country (US$ Million), 2027–2032
Table 46. AbbVie Inc. Company Details
Table 47. AbbVie Inc. Business Overview
Table 48. AbbVie Inc. CGRP Targeting Drugs for Migraine Product
Table 49. AbbVie Inc. Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 50. AbbVie Inc. Recent Development
Table 51. Pfizer Inc. Company Details
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. CGRP Targeting Drugs for Migraine Product
Table 54. Pfizer Inc. Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 55. Pfizer Inc. Recent Development
Table 56. Lundbeck Company Details
Table 57. Lundbeck Business Overview
Table 58. Lundbeck CGRP Targeting Drugs for Migraine Product
Table 59. Lundbeck Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 60. Lundbeck Recent Development
Table 61. Alder Therapeutics Company Details
Table 62. Alder Therapeutics Business Overview
Table 63. Alder Therapeutics CGRP Targeting Drugs for Migraine Product
Table 64. Alder Therapeutics Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 65. Alder Therapeutics Recent Development
Table 66. Teva Company Details
Table 67. Teva Business Overview
Table 68. Teva CGRP Targeting Drugs for Migraine Product
Table 69. Teva Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 70. Teva Recent Development
Table 71. Lilly Inc. Company Details
Table 72. Lilly Inc. Business Overview
Table 73. Lilly Inc. CGRP Targeting Drugs for Migraine Product
Table 74. Lilly Inc. Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 75. Lilly Inc. Recent Development
Table 76. Amgen Inc. Company Details
Table 77. Amgen Inc. Business Overview
Table 78. Amgen Inc. CGRP Targeting Drugs for Migraine Product
Table 79. Amgen Inc. Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 80. Amgen Inc. Recent Development
Table 81. Novartis International AG Company Details
Table 82. Novartis International AG Business Overview
Table 83. Novartis International AG CGRP Targeting Drugs for Migraine Product
Table 84. Novartis International AG Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 85. Novartis International AG Recent Development
Table 86. Daiichi Sankyo Co., Ltd. Company Details
Table 87. Daiichi Sankyo Co., Ltd. Business Overview
Table 88. Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Product
Table 89. Daiichi Sankyo Co., Ltd. Revenue in CGRP Targeting Drugs for Migraine Business (US$ Million), 2021–2026
Table 90. Daiichi Sankyo Co., Ltd. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report


List of Figures
Figure 1. CGRP Targeting Drugs for Migraine Picture
Figure 2. Global CGRP Targeting Drugs for Migraine Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global CGRP Targeting Drugs for Migraine Market Share by Type: 2025 vs 2032
Figure 4. CGRP Receptor Antagonists Features
Figure 5. CGRP Monoclonal Antibodies Features
Figure 6. Global CGRP Targeting Drugs for Migraine Market Size by Application (US$ Million), 2021–2032
Figure 7. Global CGRP Targeting Drugs for Migraine Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Specialty Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. CGRP Targeting Drugs for Migraine Report Years Considered
Figure 12. Global CGRP Targeting Drugs for Migraine Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global CGRP Targeting Drugs for Migraine Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global CGRP Targeting Drugs for Migraine Market Share by Region: 2025 vs 2032
Figure 15. Global CGRP Targeting Drugs for Migraine Market Share by Players in 2025
Figure 16. Global CGRP Targeting Drugs for Migraine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by CGRP Targeting Drugs for Migraine Revenue in 2025
Figure 18. North America CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America CGRP Targeting Drugs for Migraine Market Share by Country (2021–2032)
Figure 20. United States CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe CGRP Targeting Drugs for Migraine Market Share by Country (2021–2032)
Figure 24. Germany CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific CGRP Targeting Drugs for Migraine Market Share by Region (2021–2032)
Figure 32. China CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America CGRP Targeting Drugs for Migraine Market Share by Country (2021–2032)
Figure 40. Mexico CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa CGRP Targeting Drugs for Migraine Market Share by Country (2021–2032)
Figure 44. Israel CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE CGRP Targeting Drugs for Migraine Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. AbbVie Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 48. Pfizer Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 49. Lundbeck Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 50. Alder Therapeutics Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 51. Teva Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 52. Lilly Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 53. Amgen Inc. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 54. Novartis International AG Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 55. Daiichi Sankyo Co., Ltd. Revenue Growth Rate in CGRP Targeting Drugs for Migraine Business (2021–2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies